| Nome |
# |
|
Therapeutic potential of resveratrol against emerging respiratory viral infections, file e3835327-5412-15e8-e053-a505fe0a3de9
|
253
|
|
Chlamydia trachomatis and Chlamydia pneumoniae Interaction with the Host. Latest advances and future prospective., file e3835321-59ca-15e8-e053-a505fe0a3de9
|
156
|
|
Selected immunological mediators and cervical microbial signatures in women with chlamydia trachomatis infection, file e3835321-7d2b-15e8-e053-a505fe0a3de9
|
132
|
|
Chlamydia pneumoniae clinical isolate from gingival crevicular fluid. A potential atherogenic strain, file e3835314-7a67-15e8-e053-a505fe0a3de9
|
121
|
|
RESVERATROL IN CHLAMYDIA PNEUMONIAE-INDUCED FOAM CELL FORMATION AND INTERLEUKIN-17A SYNTHESIS, file e3835311-ce31-15e8-e053-a505fe0a3de9
|
106
|
|
Growth kinetics of Chlamydia trachomatis in primary human Sertoli cells, file e3835321-913a-15e8-e053-a505fe0a3de9
|
100
|
|
Biofilm in genital ecosystem: a potential risk factor for Chlamydia trachomatis infection., file e3835321-ac59-15e8-e053-a505fe0a3de9
|
98
|
|
Chlamydia pneumoniae-mediated inflammation in atherosclerosis: a meta-analysis., file e3835314-c124-15e8-e053-a505fe0a3de9
|
95
|
|
Infectious agents in atherosclerotic cardiovascular diseases through oxidative stress, file e3835319-a86f-15e8-e053-a505fe0a3de9
|
92
|
|
A simple, fast and reliable scan-based technique as a novel approach to quantify intracellular bacteria, file e3835323-aabc-15e8-e053-a505fe0a3de9
|
91
|
|
Antibacterial activity and impact of different antiseptics on biofilm-contaminated implant surfaces, file e3835324-0006-15e8-e053-a505fe0a3de9
|
91
|
|
Diversity of cervical microbiota in asymptomatic chlamydia trachomatis genital infection: a pilot study, file e3835317-c752-15e8-e053-a505fe0a3de9
|
90
|
|
Oxidative Stress and Inflammation in SARS-CoV-2- and Chlamydia pneumoniae-Associated Cardiovascular Diseases, file e383532c-48b7-15e8-e053-a505fe0a3de9
|
87
|
|
Interferon-γ possesses anti-microbial and immunomodulatory activity on a Chlamydia Trachomatis infection model of primary human synovial fibroblasts, file e3835324-bbb2-15e8-e053-a505fe0a3de9
|
84
|
|
Infectious burden and atherosclerosis. A clinical issue, file e3835312-b918-15e8-e053-a505fe0a3de9
|
80
|
|
Effects of Mentha suaveolens essential oil on C. trachomatis, file e3835319-d54c-15e8-e053-a505fe0a3de9
|
69
|
|
Effect of bovine lactoferrin on chlamydia trachomatis infection and inflammation., file e3835316-5706-15e8-e053-a505fe0a3de9
|
67
|
|
Extra virgin olive oil-based green formulations with promising antimicrobial activity against drug-resistant isolates, file e383532e-9226-15e8-e053-a505fe0a3de9
|
59
|
|
In-cell western assay as a high-throughput approach for Chlamydia trachomatis quantification and susceptibility testing to antimicrobials, file e383532b-f1ad-15e8-e053-a505fe0a3de9
|
44
|
|
Chlamydia pneumoniae and oxidative stress in cardiovascular disease. State of the art and prevention strategies., file e3835314-1b30-15e8-e053-a505fe0a3de9
|
40
|
|
Better in vitro tools for exploring Chlamydia trachomatis pathogenesis, file 1d9b5212-ceb1-4821-ba7a-191666c61b66
|
38
|
|
What is the Hidden Biological Mechanism Underlying the Possible SARS-CoV-2 Vertical Transmission? A Mini Review, file e383532f-2edc-15e8-e053-a505fe0a3de9
|
33
|
|
The potential role of hypochlorhydria in the development of duodenal dysbiosis. A preliminary report, file e383532f-2edb-15e8-e053-a505fe0a3de9
|
31
|
|
In vitro modelling of Chlamydia trachomatis infection in the Etiopathogenesis of male infertility and reactive arthritis, file e383532e-597c-15e8-e053-a505fe0a3de9
|
26
|
|
Towards a Deeper Understanding of Chlamydia trachomatis Pathogenetic Mechanisms: Editorial to the Special Issue “Chlamydia trachomatis Pathogenicity and Disease”, file e383532e-95c8-15e8-e053-a505fe0a3de9
|
26
|
|
Potential IFNγ modulation of inflammasome pathway in Chlamydia trachomatis infected synovial cells, file e383532e-0422-15e8-e053-a505fe0a3de9
|
22
|
|
Cervicovaginal microbiota composition in Chlamydia trachomatis infection. A systematic review and meta-analysis, file 17f9dc89-74c6-45bb-ba9d-28fe4a2a1818
|
19
|
|
SARS-CoV-2 vertical transmission in a twin-pregnant woman. A case report, file e1cee8ec-f8c0-42ce-b2b2-e2a961dd712a
|
18
|
|
Impact of air pollution on the composition and diversity of human gut microbiota in general and vulnerable populations. A systematic review, file abbbd54a-ec3c-432a-a085-c128d1434e45
|
17
|
|
Chlamydia trachomatis elicits TLR3 expression but disrupts the inflammatory signaling down-modulating NFκB and IRF3 transcription factors in human Sertoli cells, file e3835327-bd0e-15e8-e053-a505fe0a3de9
|
14
|
|
Chlamydia pneumoniae and osteoporosis-associated bone loss: A new risk factor?, file e3835311-f3f6-15e8-e053-a505fe0a3de9
|
13
|
|
Analysis of gene expression in penicillin G induced persistence of Chlamydia pneumoniae, file e3835313-bdd5-15e8-e053-a505fe0a3de9
|
13
|
|
SARS-CoV-2 infection in pregnancy. Clues and proof of adverse outcomes, file ae106736-6b6d-4dcc-a6ef-c19648842b41
|
12
|
|
Lactobacilli-lactoferrin interplay in Chlamydia trachomatis infection, file e3835319-a98c-15e8-e053-a505fe0a3de9
|
12
|
|
In-silico functional metabolic pathways associated to Chlamydia trachomatis genital infection, file aa1cab63-f5d0-4748-a7d0-b9746b996d92
|
11
|
|
Human colonic myogenic dysfunction induced by mucosal lipopolysaccharide translocation and oxidative stress, file e3835311-ce32-15e8-e053-a505fe0a3de9
|
11
|
|
Could past Chlamydial vascular infection promote the dissemination of Chlamydia pneumoniae to the brain?, file e3835319-a6bb-15e8-e053-a505fe0a3de9
|
10
|
|
Prevalence of Clamydia pneumoniae in peripheral blood mononuclear cells in italian patients with acute ischaemic heart disease, file e3835319-ab73-15e8-e053-a505fe0a3de9
|
10
|
|
Selected immunological mediators and cervical microbial signatures in women with chlamydia trachomatis infection, file e3835322-2f1e-15e8-e053-a505fe0a3de9
|
10
|
|
Chlamydia pneumoniae infection and atherosclerotic coronary disease, file e3835319-cb42-15e8-e053-a505fe0a3de9
|
9
|
|
Chlamydia pneumoniae DNA in patients with symptomatic carotid atherosclerotic disease, file e3835319-d9b8-15e8-e053-a505fe0a3de9
|
9
|
|
Chlamydia pneumoniae infection is associated with coronary artery disease but not implicated in inducing plaque instability, file e3835311-e4aa-15e8-e053-a505fe0a3de9
|
8
|
|
Chlamydia pneumoniae in PBMC: Reproducibility of the OMPA nested touchdown PCR, file e3835319-a868-15e8-e053-a505fe0a3de9
|
8
|
|
CHLAMYDIA PNEUMONIAE INFECTION AS A RISK FACTOR FOR ACCELERATED ATHEROSCLEROSIS IN HEMODIALYSIS PATIENTS, file e3835311-db95-15e8-e053-a505fe0a3de9
|
7
|
|
Effects of vaginal lactobacilli in Chlamydia trachomatis infection, file e3835312-61e9-15e8-e053-a505fe0a3de9
|
7
|
|
The elusive but pathogenic peptidoglycan of chlamydiae, file e3835313-be88-15e8-e053-a505fe0a3de9
|
7
|
|
New insights into Chlamydiae persistence: An energy metabolism strategy?, file e3835314-1c01-15e8-e053-a505fe0a3de9
|
7
|
|
HPV/Chlamydia trachomatis co-infection. Metagenomic analysis of cervical microbiota in asymptomatic women, file e3835319-b99c-15e8-e053-a505fe0a3de9
|
6
|
|
Measurement of Chlamydia pneumoniae bacterial load in peripheral blood mononuclear cells may be helpful to assess the state of chlamydial infection in patients with carotid atherosclerotic disease, file e3835311-95e5-15e8-e053-a505fe0a3de9
|
5
|
|
Chlamydia pneumoniae induces T cell apoptosis through glutathione redox imbalance and secretion of TNF-alpha., file e3835311-de31-15e8-e053-a505fe0a3de9
|
5
|
|
Detection of Chlamydia pneumoniae in atherosclerotic coronary arteries, file e3835311-f868-15e8-e053-a505fe0a3de9
|
5
|
|
Biofilm formation on the surface of ceramic tiles, file e3835319-d176-15e8-e053-a505fe0a3de9
|
5
|
|
Apyrase, the product of the virulence plasmid-encoded phoN2 (apy) gene of Shigella flexneri, is necessary for proper unipolar IcsA localization and for efficient intercellular spread, file e3835311-800c-15e8-e053-a505fe0a3de9
|
4
|
|
CHLAMYDIA PNEUMONIAE AND ATHEROSCLEROSIS: CURRENT STATE AND FUTURE PROSPECTIVES, file e3835311-af16-15e8-e053-a505fe0a3de9
|
4
|
|
Chlamydia pneumoniae in asymptomatic carotid atherosclerosis, file e3835311-c4e2-15e8-e053-a505fe0a3de9
|
4
|
|
CUTANEOUS INFECTION OF NOCARDIA ALTAMIRENSIS: THE FIRST CASE REPORT, file e3835314-1b9a-15e8-e053-a505fe0a3de9
|
4
|
|
Lack of association of Chlamydia pneumoniae with cardiovascular diseases in virologically suppressed HIV patients, file e3835316-ad58-15e8-e053-a505fe0a3de9
|
4
|
|
Chlamydia pneumoniae as risk factor of cardiovascular disease in dialysis patients, file e3835319-f8fa-15e8-e053-a505fe0a3de9
|
4
|
|
Interferon-ε as potential inhibitor of Chlamydia trachomatis infection, file a12ddbc5-adc7-4ca8-9ea2-4ed9ff917fbb
|
3
|
|
Extra virgin olive oil-based formulations. A "green" strategy against Chlamydia trachomatis, file d0788f4e-2a0b-48ca-b920-b427a2eb7baa
|
3
|
|
Chlamydia pneumoniae infection in atherosclerotic lesion development through oxidative stress: A brief overview, file e3835311-ce30-15e8-e053-a505fe0a3de9
|
3
|
|
Chlamydia pneumoniae infection in patients with acute coronary syndrome: A clinical and serological 1-year follow-up, file e3835319-b3d4-15e8-e053-a505fe0a3de9
|
3
|
|
Could Chlamydia pneumoniae be considered an infectious risk factor for inflammatory diseases such as atherosclerosis?, file e3835319-c911-15e8-e053-a505fe0a3de9
|
2
|
|
No evidence of involvement of Chlamydia pneumoniae in lung cancer by means of quantitative real-time polymerase chain reaction, file e3835319-ed8e-15e8-e053-a505fe0a3de9
|
2
|
|
CHLAMYDIA PNEUMONIAE AND ATHEROSCLEROSIS: THE ROLE OF MAST CELLS, file e3835311-af1b-15e8-e053-a505fe0a3de9
|
1
|
| Totale |
2.430 |